CVE-2026-92886: Missing Authorization vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute eta-register al
CVE-2026-92886 is a high-severity flaw (CVSS 7.8) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Missing Authorization vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute eta-register allows Privilege Escalation. This issue affects eta-register: from 2.0.8 before 2.0.9.
Why this priority
- High severity
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 7.8 (High) |
| Attack vector | Local |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | n/a |
| CISA exploited list | No |
| Weakness | CWE-862 |
| Published | 2026-11-02 |
| Last modified | 2026-11-02 |
Last updated 2026-11-02 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Timeline
- Published CVE record published
- Updated Record last modified
Advisories and coverage
Research and news
- Vulners Bulletins: CVE-2026-92886 2026-11-02
- VulDB Recent Entries: CVE-2026-92886 | eta-register up to 2.0.8 privileges management 2026-11-02
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-92886?
No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.
Is CVE-2026-92886 being exploited?
CVE-2026-92886 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-92886 affect?
CVE-2026-92886 affects affected software. Severity is high (CVSS 7.8). Missing Authorization vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute eta-register allows Privilege Escalation. This issue affects eta-register: from 2.0.8 before 2.0.9.
How urgent is CVE-2026-92886?
Priority 27/100. High severity